8-KThe WireStrategic
Material Agreement · Equity Issuance
Filed Jun 3, 2025 · 1y ago · Accession 0001213900-25-050329
Plain English
Material event — a significant development the company must disclose promptly.
Read the source below for the full document.
Filing details
- Company
- Estrella Immunopharma, Inc.
- Ticker
- ESLAW
- CIK
- 1844417
- Form type
- 8-K
- Filing date
- Jun 3, 2025
- Report date
- May 30, 2025
- Document
- ea0244428-8k_estrella.htm
- Size
- 416 KB